Clinical trial

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

NCT01176903

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2021-10-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)unresolved

Interventions

GlycopyrrolateDRUG · verified · RxNorm: glycopyrrolate

TiotropiumDRUG · verified · RxNorm: tiotropium

placeboDRUG

Sponsors & collaborators

Chiesi Farmaceutici S.p.A.lead sponsor

Mapped research locations

ManchesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01176903 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.